Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Admera Health
South Plainfield, New Jersey, United States
- Ownership
- Private
- Employees
- ~51
- Development stage
- Other
01
Overview
Admera Health offers validated, CLIA- and CAP-accredited commercial diagnostic and sequencing services in oncology, pharmacogenomics, and cardiovascular disease. Their NGS-based diagnostic products (PGxOne Plus, OncoGxOne, CardioGxOne) are in clinical use for actionable, guideline-supported genetic insights to inform patient management[1][3][5].
- Therapeutic areas
- CardiovascularOncologyOtherNeurology
- Modalities
- Genomic testingBioinformatic analysisNext-generation sequencing
- Industry
- Molecular Diagnostics
02
Partnerships
Rosetta GenomicsBioEchoNGX Bio (acquisition, expanded NGS marketplace)
Beyond the preview
Go deeper on Admera Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Admera Health.